Quantcast
Last updated on April 23, 2014 at 11:02 EDT

Latest Positron Corporation Stories

2012-10-16 11:25:26

CHICAGO, Oct. 16, 2012 /PRNewswire/ -- Positron Corporation announced today that the United States Patent and Trademark Office (USPTO) has awarded the Company a patent (U.S. No. 8,269,181) for its original semiconductor detector used in high precision measuring of coordinates and detection of ionization particles. The technology and patent issuance was achieved through collaboration with Dr. Valeri Saveliev of DESY in Hamburg, Germany. Dr. Saveliev's expertise in avalanche pixel...

2012-10-09 11:28:26

LUBBOCK, Texas, Oct. 9, 2012 /PRNewswire/ -- Positron Corporation, (OTCBB:POSC) a molecular imaging healthcare company, announces that their subsidiary, Manhattan Isotope Technology, LLC, has received an acknowledgment letter and Drug Master File (DMF) number assignment, from the United States Food & Drug Administration (FDA), for its Strontium-82 Drug Substance. Manhattan Isotope Technology (MIT) has received acknowledgment from the FDA for its Strontium-82 Drug Substance...

2012-09-27 06:28:49

LUBBOCK, Texas, Sept. 27, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a molecular imaging healthcare company will be presenting at the 1(st) International Business Conference for Producers, Suppliers and Consumers of Isotope Products (1IBCI), which will take place in Moscow, Russia, October 1(st )- 3(rd), 2012. The 1IBCI conference, organized by Isotope Co., an entity within the Rosatom State Atomic Energy Corporation's (ROSATOM) Program "Radiation Technologies," will...

2012-09-06 02:30:48

BALTIMORE, Sept. 6, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC), - is pleased to announce that Jubilant DraxImage Inc. (hereinafter "JDI"), a Jubilant Life Sciences Company, and Positron Corporation (hereinafter "Positron"), have executed a Letter of Intent pertaining to: (a) Positron's supply of Active Pharmaceutical Ingredient (API) grade Sr-82 for the JDI Sr-82/Rb-82 generator; (b) JDI's and Positron's co-promotion of JDI Sr-82/Rb-82 generators to end-users...

2012-08-22 10:24:31

LUBBOCK, Texas, Aug. 22, 2012 /PRNewswire/ -- Positron Corporation, (OTCBB:POSC) a leading molecular imaging healthcare company, is pleased to announce the submission of a Drug Master File (DMF), with the Federal Drug Administration (FDA), for the production of Active Pharmaceutical Ingredient (API) grade strontium-82, through its wholly owned subsidiary Manhattan Isotope Technology, LLC. A Drug Master File (DMF) is a document submitted to the FDA, which contains complete information on an...

2012-08-20 06:28:15

CHICAGO, Aug. 20, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC) a leading molecular imaging healthcare company, is pleased to announce the FDA's marketing approval of The University of Texas Health Science Center at Houston (UTHealth) Coronary Flow Reserve (CFR) quantification software, cfrQuant(TM). The cfrQuant(TM) software was developed under the guidance of K. Lance Gould, M.D., and the Weatherhead PET Imaging Center of the UTHealth Medical School, with contributions of...

2012-08-17 06:22:11

CHICAGO, Aug. 17, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a leading molecular imaging healthcare company, is pleased to announce that Neusoft Positron Medical Systems Co., Ltd., has received ISO certification (9001:2008 & 13485:2003) and CE Mark approval for their Attrius® PET Systems. Neusoft Positron Medical Systems is a joint venture between Neusoft Medical Systems Co., Ltd., and Positron Corporation for the development and manufacturing of PET systems and is based...

2012-08-16 06:24:59

CHICAGO, Aug. 16, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC) a leading molecular imaging healthcare company is pleased to announce the use of their Attrius system at Caring Heart and Brain Imaging Inc., of Manasquan, New Jersey, which now offers Amyvid PET scans to identify the presence of plaque in the brain, which has been shown to be a precursor to Alzheimer's disease. Amyvid(TM) (Florbetapir F-18 Injection) is indicated for Positron Emission Tomography (PET) imaging of the...

2012-08-07 02:29:45

LUBBOCK, Texas, Aug. 7, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC) a leading molecular imaging healthcare company is pleased to announce the consolidation and integration of operations at the Crown Point, Indiana facility to its Lubbock, Texas site. With the acquisition of Manhattan Isotope Technology (MIT), Positron gained the expertise, knowledge and radioactive materials facilities to manage all of the Company's radiopharmaceutical and radioisotope development,...

2012-07-20 06:22:25

GARY, Ind., July 20, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a leading molecular imaging healthcare company, announces approval of a Pledge Resolution for $15 Million in Tax Increment Financing (TIF) Bonds, from the Redevelopment Commission of the City of Gary, Indiana towards the development of Positron's 70 MeV cyclotron project. In addition to the TIF incentives, the City of Gary will assist in sourcing the appropriate allocation of New Market Tax Credits (NMTC) that could...